trending Market Intelligence /marketintelligence/en/news-insights/trending/0ZoM-dTPJUiOlLaZwyLpxQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

RavenQuest BioMed completes C$2.1M placement of units

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

RavenQuest BioMed completes C$2.1M placement of units

RavenQuest BioMed Inc. completed a private placement of units to raise gross proceeds of C$2.1 million.

The Vancouver, British Columbia-based cannabis company sold 3,523,832 units at 60 Canadian cents each.

Each unit consists of one common share of the company and one half of a share purchase warrant. The two-year warrants are exercisable at 80 cents per common share, subject to accelerated expiry if the closing price of RavenQuest's shares exceed C$1.60 for 10 consecutive trading days.

RavenQuest plans to use the proceeds for general corporate purposes.